Synthesis and biological activity of new rhodanine-triazole conjugates with 2-(2,6-dichlorophenylamino)benzyl moiety in the molecules
DOI:
https://doi.org/10.14739/2409-2932.2020.2.207024Keywords:
synthesis, 4H-1, 2, 4-triazole, rhodanine, diclofenac, anti-inflammatory activity, anticancer activityAbstract
Molecular design of “drug-like” molecules based on the combination of a fragment of non-steroidal anti-inflammatory drug diclofenac with a pharmacologically attractive 1,2,4-triazole and 4-thiazolidinone “structural matrices” in one molecule is an effective approach in modern medical chemistry.
Aim. Synthesis of new rhodanine-triazole hybrid molecules (conjugates) with 2- (2,6-dichlorophenylamino) benzyl moiety and evaluation of their biological activity.
Materials and methods. The method of rhodanine-triazoles synthesis was elaborated. The structures of the synthesized compounds were confirmed by elemental analysis, NMR spectroscopy, and LCMS. The anti-exudative activity of the compounds was investigated in a rat carrageenan edema model, and the antitumor effect was studied in vitro at a concentration of 10-5 M on 60 cancer cell lines (DTP NCI Program).
Results. Novel 2-{5-[2-(2,6-dichlorophenylamino)-benzyl]-4H-1,2,4-triazol-3-ylsulfanyl}-N-(4-oxo-2-thioxothiazolidin-3-yl)-acetamides and their 5-arylidene derivatives were synthesized/ Among these derivatives hit compounds with anti-inflammatory and anticancer activity against cell lines of melanoma, leukemia, non-small cell lung cancer, colon cancer, CNS cancer, ovarian cancer, renal cancer, and breast cancer were identified.
Conclusion. The molecular design of rhodanine-triazole hybrid molecules based on diclofenac is an effective approach to the search for novel anti-inflammatory and antitumor agents.
References
- Palkar, M. B., Singhai, A. S., Ronad, P. M., Vishwanathswamy, A. H. M., Boreddy, T. S., Veerapur, V. P., Shaikh, M. S., Rane, R. A., & Karpoormath, R. (2014). Synthesis, pharmacological screening and in silico studies of new class of Diclofenac analogues as a promising anti-inflammatory agents. Bioorganic & Medicinal Chemistry, 22(10), 2855-2866. https://doi.org/10.1016/j.bmc.2014.03.043
- Kumar, S. S., & Kavitha, H. P. (2013). Synthesis and Biological Applications of Triazole Derivatives – A Review. Mini-Reviews in Organic Chemistry, 10(1), 40-65. https://doi.org/10.2174/1570193X11310010004
- Havrylyuk, D., Roman, O., & Lesyk, R. (2016). Synthetic approaches, structure activity relationship and biological applications for pharmacologically attractive pyrazole/pyrazoline-thiazolidine-based hybrids. European Journal of Medicinal Chemistry, 113, 145-166. https://doi.org/10.1016/j.ejmech.2016.02.030
- Kaminskyy, D., Kryshchyshyn, A., & Lesyk, R. (2017). 5-Ene-4-thiazolidinones – An efficient tool in medicinal chemistry. European Journal of Medicinal Chemistry, 140, 542-594. https://doi.org/10.1016/j.ejmech.2017.09.031
- Kaminskyy, D., Kryshchyshyn, A., & Lesyk, R. (2017b). Recent developments with rhodanine as a scaffold for drug discovery. Expert Opinion on Drug Discovery, 12(12), 1233-1252. https://doi.org/10.1080/17460441.2017.1388370
- Amir, M., & Shikha, K. (2004). Synthesis and anti-inflammatory, analgesic, ulcerogenic and lipid peroxidation activities of some new 2- (2,6-dichloroanilino) phenyl acetic acid derivatives. European Journal of Medicinal Chemistry, 39(6), 535-545. https://doi.org/10.1016/j.ejmech.2004.02.008
- Shepeta, Yu. L., Lelyukh, M. I., Zimenkovsky, B. S., Lesyk, R. B. (2016). Syntez novykh pokhidnykh 4N-1,2,4-triazol-3-tiolu z 2-(2,6-dykhlorofenilamino)benzylnym frahmentom u molekulakh ta yikhnia protyzapalna aktyvnist [Synthesis of novel 4H-1,2,4-triazole-3-thiol derivatives with 2-(2,6-dichlorophenylamino)benzyl moiety in molecules and their anti-inflammatory activity]. Current issues in pharmacy and medicine: science and practice, 20(1), 18-25. [in Ukrainian]. https://doi.org/10.14739/2409-2932.2016.1.61103
- Nektegayev, I., & Lesyk, R. (1999). 3-Oxyarylthiazolidones-4 and their choleretic activity. Scientia Pharmaceutica, 67, 227-230.
- Havrylyuk, D., Mosula, L., Zimenkovsky, B., Vasylenko, O., Gzella, A., & Lesyk, R. (2010). Synthesis and anticancer activity evaluation of 4-thiazolidinones containing benzothiazole moiety. European Journal of Medicinal Chemistry, 45(11), 5012-5021. https://doi.org/10.1016/j.ejmech.2010.08.008
- Stefanov, O. V. (Ed.). (2001). Doklinichni doslidzennia likarskykh zasobiv : metodychni rekomendatsii [Preclinical studies of medicines: methodological recommendations]. Kyiv: Avitsenna. [in Ukrainian].
- Grever, M. R., Schepartz, S. A., & Chabner, B. A. (1992). The National Cancer Institute: Cancer drug discovery and development program. Seminars in Oncology, 19(6), 622-638. https://doi.org/10.5555/uri:pii:009377549290032V
- Boyd, M. R., & Pauli, K. D. (1995). Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Development Research, 34(2), 91-109. https://doi.org/10.1002/ddr.430340203
- Popov-Pergal, K., Chekovich, Zh., & Pergal, M. (1991). Kondensatsiya 2,4-tetragidro-1,3-tiazola s aromaticheskimi aldegidami [Condensation of 2,4-tetrahydro-1,3-thiazole with aromatic aldehydes]. Zhurnal organicheskoi khimii, 61(9), 2112-2116. [in Russian].
- Roman, O., & Lesyk, R. (2007). Synthesis and anticancer activity in vitro of some 2-thioxo-4-thiazolidone derivatives. Farmacia, 55(6), 640-648.
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
